Henry Meds vs Wisp

Neither Henry Meds nor Wisp has an FDA warning letter on record. On compounded oral semaglutide, Wisp costs $288 less a year at standing rates: $225 a month against $249 a month at Henry Meds.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Henry Meds / Wisp

Henry Meds logo

Henry Meds

5.6/10

Wisp logo

Wisp

7.1/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$249/moCompounded oral semaglutide
$225/moCompounded oral semaglutide
States
No state list published
39 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026

Neither Henry Meds nor Wisp pays us. Links to them earn nothing. Scores: Henry Meds 5.6, Wisp 7.1. How we are paid

What the record shows

  1. 01

    Neither Henry Meds nor Wisp has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    On compounded oral semaglutide, Wisp costs $288 less a year at standing rates: $225 a month against $249 a month at Henry Meds.

  4. 04

    Only Henry Meds lists a price for compounded semaglutide injection and compounded tirzepatide injection.

  5. 05

    Wisp lists 39 states. Henry Meds publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Henry Meds

Wisp

Compounded oral semaglutide

$249/mo

$2,988 a year

$225/moLower

$2,700 a year

Compounded semaglutide injection

$297/mo

$3,564 a year

Not sold or not priced
Compounded tirzepatide injection

$349/mo

$4,188 a year

Not sold or not priced
Price includes
Medication, clinician visits, shipping
Medication, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on monthly plans; longer plans are offered for some treatments
Not stated
Refunds
Subscription fees generally non-refundable; medication is final sale once shipped
All sales are final
Early-exit fee
Yes
Not stated

Read off each seller’s own pages. Henry Meds: October 30, 2026. Wisp: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Henry Meds

5.6/10
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Wisp does not price
  • Names no compounding pharmacy
  • Publishes no state list

The case for Wisp

7.1/10
  • $288 a year less on compounded oral semaglutide
  • Names no compounding pharmacy

Scores

Henry Meds 5.6 · Wisp 7.1 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
4.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

4.0A
vs
B
7.5

Accessibility10%

5.0A
vs
B
8.2

Support10%

7.0A
vs
B
4.5

The score is the same formula for every seller. Payment does not enter it. Method

Henry Meds vs Wisp: questions

Neither Henry Meds nor Wisp has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
Wisp, by $288 a year at standing rates. Henry Meds: $249 a month, about $2,988 a year. Wisp: $225 a month, about $2,700 a year.
Henry Meds states you can cancel at any time; refunds: subscription fees generally non-refundable; medication is final sale once shipped. Wisp states you can cancel at any time; refunds: all sales are final.
Neither Henry Meds nor Wisp pays us. Links to them earn nothing. Scores: Henry Meds 5.6, Wisp 7.1.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register